top of page

Long-term culture based on dendritic cell activity/inactivity control technology

Development of regulatory techniques that exist in a functionally inactive state while maintaining the survival of primary dendritic cells separated from immune tissue to devour antigens and turn into active forms if immune or inflammatory stimulation is received

Development of a culture method that can be cultured without activation by a combination of fibronectin-derived peptides (PHSRN, RGD, and LDV peptides) and induce activity of dendritic cells by adding stimulants

core tech1.png

T cell activation technology by primary dendritic cells

Primary dendritic cells vs Differentiated dendritic cells

  • Differences in subtypes between primary dendritic cells and inflammatory differentiated dendritic cells → Differences in T cell activity → Differences in anti-tumor efficacy

  • Separated super dendritic cells → Presence of the same subtype in the body

core tech2.png

Development of the primary dendritic cell as a powerful anti-cancer immune cell therapy

Identification of Dendritic Cell Self-Activation Regulatory Substances

Discovery of Self-Activating Target-Based Inhibitors for Dendritic Cells

Using the developed system, various kinds of regulatory factors that can secure the defense of patent rights and the rights of family patents are identified, and patent rights are secured

core tech3.png
bottom of page